Geopolitics & Trade

A new partnership aims to secure the growing army of non-human AI agents, promising rapid, secure deployment. But can it solve AI's identity crisis?

Following a record year, Knight Therapeutics is doubling its share repurchase plan. We analyze the strategy, financials, and what it means for investors.

With the appointment of Jack Azagury as CEO, Insight Enterprises signals an aggressive pivot to AI, banking on his transformation expertise to lead a new era.

With two new strategic partnerships, YSX Tech is deploying AI, drones, and blockchain to revolutionize insurance claims and capture a piece of China's booming market.

The firm's new 'TrueRisk' model offers unprecedented flexibility, but industry watchers question the sustainability and underlying risks of this new approach.

As Carlton Fields marks its 125th anniversary, a look at its pioneering history of diversity, strategic expansion, and enduring impact on the legal profession.

Splitit's new mobile solution lets contractors and doctors offer installments on existing credit cards, targeting a $4.6 trillion face-to-face market.

With a new $40M loan, Hyperfine is set to accelerate the rollout of its Swoop® system, bringing AI-powered brain imaging directly to the patient's bedside.

A new partnership will use predictive simulation to design ultra-durable alloys for The Exploration Company's Nyx, accelerating the future of space logistics.

Following the Baker Tilly merger, Moss Adams' wealth unit launches as Threadline Wealth, an independent RIA backed by Cynosure to target HNW clients.

Karma Automotive's new on-demand service in Vegas isn't just about cars; it's a bet on the future of ultra-luxury experiences. Here's why.

An investor turns an office building into 14 alternative assets, showcasing a complex 1031 exchange strategy driven by state housing mandates and market shifts.

A new report shows the US food and agriculture sector is a $10.4T economic powerhouse, but declining exports and flat job growth reveal serious challenges.

Canadian law firms are adopting AI faster than global peers to boost profits, creating a performance gap and raising complex new ethical questions.

A small firm just topped industry giants in advisor satisfaction. Here's how its independent, no-conflict model is winning in alternative investments.

The Texas fuel supplier is preparing a Nasdaq/NYSE move, banking on high energy prices from the Iran War to bolster its financials for the ambitious jump.

A major chemical firm is raising prices, revealing how Red Sea disruptions and market volatility directly impact costs for pharma, personal care, and more.

With a new grant, Tessera Therapeutics is advancing its novel Gene Writing platform to engineer a scalable, single-shot cure for HIV. But can it work?

The L.A.-based bank extends its $300M stock repurchase program and will redeem $385M in notes, a move analysts see as a confident financial play.

A new partnership aims to end token fraud by embedding issuer identity directly into digital assets, bridging the gap between traditional and on-chain finance.